A	B	C
1	Main
2		Brand	Shingrix
3		Generic
4		MOA	Recombinant Adjuvanted vaccine, AS01B adjuvant, surface glycoprotein E antigen
5		Dosing	2 IM
6		Indication	Prevention of Herpez Zoster reactivation in ages 50+
7		Price	$220 AWP 1/1/23, $206 1/1/22, $194 1/1/21, $182 1/1/20
8		Manufacturing	CHO-K1
9		Clinical Trials
10			Phase III n=14000 - NCT01165177
11			97% reduction in shingles
12
13			Phase III n=13000 ages 70+
14			90% reduction in shingles